Senses Disorder TRIZ Cases
- Nasal Turbinate Stem Cells for Retinal Photoreceptor Regeneration
Injecting these stem cells into the subretinal space replaces damaged tissue without triggering proliferative vitreoretinopathy complications.
- NK Cell Production via Three-Stage Cytokine Regimen
Three-stage cytokine regimen produces viable NK cells, resolving low yield and functional compromise in existing expansion methods.
- Angiogenin Agonists for Muscle Growth via Myostatin Reversal
Angiogenin agonists stimulate muscle mass and strength by reversing myostatin regulatory effects.
- GPR40 Modulating Compounds for Type II Diabetes Treatment
Novel GPR40 modulating compounds regulate insulin secretion and enhance glucose uptake through AMPK pathway activation.
- Substituted Pyrazolo-Quinazoline Kinase Inhibitors for Cancer Therapy
Substituted pyrazolo-quinazoline compounds inhibit protein kinases to disrupt aberrant mitosis in cancer cells.
- ShK Peptide Kv1.3 Blockade for Dry Eye and Uveitis
ShK peptides target Kv1.3 channels to treat dry eye and uveitis without steroid-induced vision loss.
- Monoclonal Antibody Targeting HCMV gB AD1 Discontinuous Epitope
Antibody targeting discontinuous epitope in HCMV glycoprotein gB AD1 region achieves high neutralizing capacity at lower dosages, reducing side effects.
- Ophthalmic Oil-in-Water Emulsion Pre-Concentrate Dilution Process
Diluting a high-oil pre-concentrate reduces energy input and time loss while maintaining chemical stability for large-volume production.
- Sulfone Compounds Selective CB2 Agonists for Inflammation
Selective sulfone compounds activate CB2 receptors to treat inflammation and pain without triggering psychoactive effects.
- Amino Alcohol Derivative S1P Receptor Agonist for Immunosuppression
Novel amino alcohol derivative acts as an S1P receptor agonist to deliver potent immunosuppressive activity.
- CLIP Inhibitors Modulate Immune Function via MHC Binding
Computational design identifies peptides that displace CLIP from MHC molecules to modulate immune cell function.
- Triazine Derivatives as Src Kinase Inhibitors
Trianzine derivatives inhibit Src family kinases, addressing insufficient therapeutic agents for cancer.
- UPR Modulators Reduce ER Stress CHOP for Hearing Loss
Formula I compounds inhibit PERK activation to reduce CHOP expression and mitigate noise-induced hearing loss.
- Codon-Optimized rAAV Vector for LCA Treatment
Modifying CpG dinucleotide content in the RPE65 coding sequence reduces immunogenicity while maintaining therapeutic efficacy.
- scAAV2-shmTOR-SD Gene Therapy for Diabetic Retinopathy
A scAAV2-shmTOR-SD vector delivers shRNA to suppress mTOR expression in retinal cells.
- HIF-1α Inhibitor Antibodies for Refractory Eye Disease Treatment
Antibodies targeting HIF-1α block hypoxia-inducible factor activity to treat refractory retinal diseases by reducing angiogenic factors.
- Retinol Eye Compositions Sustaining Corneal Hyaluronic Acid
Retinol eye compositions stimulate corneal epithelial cells to produce endogenous hyaluronic acid.
- Cyclopentenyl Purine Derivative for Adenovirus Suppression
Modifying the purine ring structure reduces toxicity while maintaining antiviral efficacy against adenovirus.
- Corticosteroid and Kinin B2 Receptor Antagonist Compositions
Merging corticosteroids with kinin B2 receptor antagonists reduces pain while minimizing adverse gastrointestinal effects.
- Dicyanopyridine Adenosine A1 Agonists for Glaucoma
Topical dicyanopyridines selectively activate adenosine A1 receptors to reduce intraocular pressure without affecting hemodynamic parameters.
- Sortilin Crystal Structure for Ligand Identification
Sortilin crystal structure enables precise ligand identification via computer-aided modeling, preventing ternary complex formation.
- Imidamide Sphingosine Kinase Inhibitors Substrate Binding
Imidamide analogs target the unique substrate binding pocket of sphingosine kinases to achieve selective enzyme inhibition and improved oral bioavailability.
- Fused Pyridine Derivatives as Selective PI3K Inhibitors
Amino-substituted fused pyridine derivatives resolve the contradiction between potency and selectivity in PI3K inhibition.
- Pyrimidinones Modulating PI3K Activity for Disease Treatment
Pyrimidinone compounds modulate phosphoinositide 3-kinase activity, resolving the trade-off between treatment reliability and compound complexity.
- Mucus-Penetrating Nanoparticles for Drug Delivery
Mucus-penetrating nanoparticles overcome mucoadhesion to deliver drugs effectively, ensuring therapeutic efficacy in treating diseases.
- Glutarimide Derivatives for Eosinophilic Disease Treatment
Glutarimide derivatives reduce eosinophil counts to treat diseases while avoiding corticosteroid side effects.
- KTPAF50-Specific Antibodies for Lung Cancer Diagnosis
Antibodies recognizing KTPAF50 resolve low diagnostic specificity by detecting molecular markers for lung cancer treatment.
- C16:1n7 Palmitoleate Composition for Dry Eye Treatment
C16:1n7 palmitoleate composition reduces tear osmolarity and restores meibomian gland function to treat chronic dry eye disease.
- Mitochondrial DNA Modification via MTS-NES Fusion Polypeptide
A fusion polypeptide combines mitochondrial targeting and nuclear export signals to deliver DNA-binding proteins into mitochondria.
- CFH-to-F13B Locus Haplotype Analysis for AMD Risk Prediction
Segmenting the CFH-to-F13B locus into distinct gene regions resolves the contradiction between comprehensive genetic coverage and analytical complexity.
- Tissue Protective Peptides Resolving EPO Side Effects
Segmenting erythropoietin isolates tissue protective domains, resolving the contradiction between cellular protection and unwanted erythropoietic effects.